Track topics on Twitter Track topics that are important to you
CytoReason’s proprietary technology demonstrates ability to reconstruct hidden cellular signals, extrapolate one tissue to another and identify immune system relationships capab...
New Data Published by Nature Biotechnology Covering 16,000,000 scientific articles, this massive Natural Language Processing (NLP) project quadruples the reference ...
(CytoReason) New data published in Nature Biotech, represents the largest ever analysis of immune cell signaling research, mapping more than 3,000 previously unlisted cellular interactions, and yieldi...
Born out of 10 yearsâ research from Stanford and the Technion, CytoReason is the only AI company to focus entirely on the immune system in developing its proprietary data and...
We have published hundreds of CytoReason news stories on BioPortfolio along with dozens of CytoReason Clinical Trials and PubMed Articles about CytoReason for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CytoReason Companies in our database. You can also find out about relevant CytoReason Drugs and Medications on this site too.